Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Efe EworukeNicole HaugMarie C BradleyAustin CosgroveTancy ZhangElizabeth C DeeSruthi AdimadhyamAndrew PetroneHana LeeTiffany WoodworthSengwee TohPublished in: JNCI cancer spectrum (2021)
Among Caucasians, we identified small increased risks of BCC and SCC with HCTZ compared with ACEI. Appropriate risk mitigation strategies should be taken while using HCTZ.